IBO
Income statement / Annual
Last year (2025), Impact BioMedical Inc.'s total revenue was $32.00 K,
a decrease of 98.63% from the previous year.
In 2025, Impact BioMedical Inc.'s net income was -$11.84 M.
See Impact BioMedical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
| Period Ended |
12/31/2025 |
12/31/2024 |
| Operating Revenue |
$32.00 K |
$2.33 M |
| Cost of Revenue |
$424.00 K
|
$0.00
|
| Gross Profit |
-$392.00 K
|
$2.33 M
|
| Gross Profit Ratio |
-12.25
|
1
|
| Research and Development Expenses |
$340.00 K
|
$91.77 K
|
| General & Administrative Expenses |
$1.95 M
|
$1.02 M
|
| Selling & Marketing Expenses |
$24.00 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.98 M
|
$1.02 M
|
| Other Expenses |
$1.56 M
|
$670.05 K
|
| Operating Expenses |
$3.88 M
|
$1.78 M
|
| Cost And Expenses |
$4.30 M
|
$1.78 M
|
| Interest Income |
$13.00 K
|
$5.69 K
|
| Interest Expense |
$793.00 K
|
$168.95 K
|
| Depreciation & Amortization |
$1.15 M
|
$343.46 K
|
| EBITDA |
-$12.51 M |
-$1.54 M |
| EBITDA Ratio |
-391
|
-0.66
|
| Operating Income Ratio |
-133.44
|
0.24
|
| Total Other Income/Expenses Net |
-$10.18 M
|
-$2.60 M
|
| Income Before Tax |
-$14.45 M
|
-$2.05 M
|
| Income Before Tax Ratio |
-451.56
|
-0.88
|
| Income Tax Expense |
-$2.58 M
|
$0.00
|
| Net Income |
-$11.84 M
|
-$2.05 M
|
| Net Income Ratio |
-369.94
|
-0.88
|
| EPS |
-0.38 |
-0.01 |
| EPS Diluted |
-0.38 |
-0.01 |
| Weighted Average Shares Out |
$31.55 M
|
$41.75 M
|
| Weighted Average Shares Out Diluted |
$31.55 M
|
$41.75 M
|
| Link |
|
|
